Abstract | The field resistance of transgenic sugarcane plants to sugarcane mosaic potyvirus was successfully demonstrated, and a number of transgenic lines are available for consideration for agronomic evaluation. Some of the transgenic lines yielded significantly more tonnes sugar per hectare in this trial, but a firm conclusion about the overall performance of the transgenic lines compared to the parental clone can not be concluded due to the limitations of this trial. These plants contain the coat protein gene of sugarcane mosaic virus and prove that pathogen-derived resistance can be engineered into a genetically complex monocot. The precise molecular basis of the resistance appears to be RNA mediated. More research is necessary to prove this as a number of the resistant lines do not exhibit the usual RNA profiles of transgenic plants from other species which are virus resistant. A second pathogen-derived resistance gene, based on the virus replicase gene, is also capable of conferring virus resistance in sugarcane.Analysis of sugar and syrup produced from transgenic cane has revealed that no genes, native or transgenic, survive the laboratory production process. There is every confidence that this result would also be found with mill produced sugar, when the opportunity to mill transgenic sugarcane eventuates. There is now good scientific evidence to contribute to the debate that sugar manufactured from transgenic sugarcane plants is indistinguishable or substantially equivalent to sugar produced from non-transgenic plants. |